Skip to main content
. 2020 Dec 15;33(2):155–162. doi: 10.1097/BOR.0000000000000776

Table 2.

Autoantibodies detected in patients with COVID-19

Autoantibodies Clinical significance Refs.
ANA Poor prognosis and a significant higher respiratory rate [14]
APL Poor prognosis and a significant higher respiratory ratePossible association with a hyperinflammatory state and thrombosis and thromboembolism [14,52]
Lupus anticoagulant A higher rate of thrombosis [51]
Cold agglutinins Haemolytic anaemia.Complicating laboratory assessment and renal replacement therapy [55,58]
Anti-Ro/SSA antibodies Possible association with severe pneumonia [56]
Anti-Caspr2 antibody Unclear [54]
Anti-GD1b antibody Unclear [54]
Anti-MOG antibody Unclear [53]
Red cell bound antibodies Associated with the severity of anaemia [57]